Skip to main content
Industry News
Inovio, Kaneka partner for COVID-19 vaccine production
12/7/2020

Inovio Pharmaceuticals and Kaneka Eurogentec, a unit of Kaneka, a Japanese chemical company, have entered a manufacturing agreement to produce Inovio's COVID-19 vaccine candidate, although no details were disclosed regarding the deal's terms. Another manufacturing deal has also been made by Inovio with Thermo Fisher to boost its vaccine supply.

Full Story: